M6P Therapeutics is developing the next-generation enzyme replacement and gene therapies for lysosomal storage disorders. We have discovered a novel method for significantly increasing mannose-6-phosphate phosphorylation of various lysosomal enzymes. This allows for markedly improved enzyme delivery to target tissues and promises improved clinical outcomes.
Company Details
- Employees
- 20
- Founded
- 2017
- Address
- 20 S Sarah St, St Louis,missouri 63108,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- m6ptherapeutics.com
- Keywords
- Boulder.
- HQ
- St Louis, Missouri
M6p Therapeutics Questions
M6P Therapeutics's website is m6ptherapeutics.com
M6P Therapeutics's LinkedIn profile is https://www.linkedin.com/company/m6ptherapeutics
M6P Therapeutics has
20 employees.
View email and phone details for 20
employees at M6P Therapeutics.
M6P Therapeutics's industry is
Biotechnology Research
M6P Therapeutics's top competitors are
Elle Family Office,
Biovie Inc.,
Amicus Therapeutics,
Leapfrog Bio,
Simcha Therapeutics,
Seva Therapeutics Inc.,
Bolden Therapeutics,
Fleming Cfo, Inc.,
Jaya Biosciences Inc.,
Immuto Scientific.
M6P Therapeutics's categories are Biotechnology Research
M6P Therapeutics's founding year is 2017
